Honokiol Prevents Intestinal Barrier Dysfunction in Mice with Severe Acute Pancreatitis and Inhibits JAK/STAT1 Pathway and Acetylation of HMGB1
Original Article|Updated:2024-07-03
|
Honokiol Prevents Intestinal Barrier Dysfunction in Mice with Severe Acute Pancreatitis and Inhibits JAK/STAT1 Pathway and Acetylation of HMGB1
Honokiol Prevents Intestinal Barrier Dysfunction in Mice with Severe Acute Pancreatitis and Inhibits JAK/STAT1 Pathway and Acetylation of HMGB1
中国结合医学杂志(英文版)2024年30卷第6期 页码:534-542
Affiliations:
Department of General Surgery, Putuo Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai (200062), China
Author bio:
Dr. FENG Dian-xu, E-mail: fdianxu@163.com
Funds:
National Natural Science Foundation of China(81803920;81673789);Key Medical Specialty Construction Project of Shanghai Municipal Health Commission(ZK2019B18);Shanghai Putuo District Health Commission Characteristic Disease Construction Project(2020TSZB03)
Honokiol Prevents Intestinal Barrier Dysfunction in Mice with Severe Acute Pancreatitis and Inhibits JAK/STAT1 Pathway and Acetylation of HMGB1[J]. 中国结合医学杂志(英文版), 2024,30(6):534-542.
LI Jie, CHEN Ya-feng, GAO Lei, et al. Honokiol Prevents Intestinal Barrier Dysfunction in Mice with Severe Acute Pancreatitis and Inhibits JAK/STAT1 Pathway and Acetylation of HMGB1[J]. Chinese Journal of Integrative Medicine, 2024,30(6):534-542.
Honokiol Prevents Intestinal Barrier Dysfunction in Mice with Severe Acute Pancreatitis and Inhibits JAK/STAT1 Pathway and Acetylation of HMGB1[J]. 中国结合医学杂志(英文版), 2024,30(6):534-542. DOI: 10.1007/s11655-023-3562-y.
LI Jie, CHEN Ya-feng, GAO Lei, et al. Honokiol Prevents Intestinal Barrier Dysfunction in Mice with Severe Acute Pancreatitis and Inhibits JAK/STAT1 Pathway and Acetylation of HMGB1[J]. Chinese Journal of Integrative Medicine, 2024,30(6):534-542. DOI: 10.1007/s11655-023-3562-y.
Honokiol Prevents Intestinal Barrier Dysfunction in Mice with Severe Acute Pancreatitis and Inhibits JAK/STAT1 Pathway and Acetylation of HMGB1
摘要
Abstract
Objective:
2
To investigate the effect of honokiol (HON) and the role of high-mobility group protein B1 (HMGB1) on the pathogenesis of severe acute pancreatitis (SAP).
Methods:
2
Thirty mice were numbered according to weight
and randomly divided into 5 groups using a random number table
including control
SAP
SAP and normal saline (SAP+NS)
SAP and ethyl pyruvate (SAP+EP)
or SAP+HON groups
6 mice in each group. Samples of pancreas
intestine
and blood were collected 12 h after SAP model induction for examination of pathologic changes
immune function alterations by enzyme linked immunosorbent assay (ELISA)
and Western blot.
In vitro
experiments
macrophages were divided into 5 groups
the control
lipopolysaccharide (LPS)
LPS+DMSO (DMSO)
LPS+anti-HMGB1 monoclonal antibody (mAb)
and LPS+ HON groups. The tight connection level was determined by transmission electron microscopy and fluorescein isothiocyanate-labeled. The location and acetylation of HMGB1 were measured by Western blot. Finally
pyridone 6 and silencing signal transducer and activator of the transcription 1 (siSTAT1) combined with honokiol were added to determine whether the Janus kinase (JAK)/ STAT1 participated in the regulation of honokiol on HMGB1. The protein expression levels of HMGB1
JAK
and STAT1 were detected using Western blot.
Results:
2
Mice with SAP had inflammatory injury in the pancreas
bleeding of intestinal tissues
and cells with disrupted histology. Mice in the SAP+HON group had significantly fewer pathological changes. Mice with SAP also had significant increases in the serum levels of amylase
lipase
HMGB1
tumor necrosis factor-α
interleukin-6
diamine oxidase
endotoxin-1
and procalcitonin. Mice in the SAP+HON group did not show these abnormalities (
P
<
0.01). Studies of Caco-2 cells indicated that LPS increased the levels of occludin and claudin-1 as well as tight junction permeability
decreased the levels of junctional adhesion molecule C
and elevated intercellular permeability (
P
<
0.01). HON treatment blocked these effects. Studies of macrophages indicated that LPS led to low nuclear levels of HMGB1
however
HON treatment increased the nuclear level of HMGB1 (
P
<
0.01). HON treatment also inhibited the expressions of JAK1
JAK2
and STAT1 (
P
<
0.01) and increased the acetylation of HMGB1 (
P
<
0.05).
Conclusion:
2
HON prevented intestinal barrier dysfunction in SAP by inhibiting HMGB1 acetylation and JAK/STAT1 pathway.
关键词
Keywords
severe acute pancreatitisintestinal barrier dysfunctionhonokiolhigh-mobility group protein B1Janus kinasesignal transducer and activator of transcription 1